In one paragraphArticle in International journal of environmental research and public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Mayara Calixto da SilvaResearch Laboratory of Pharmaceutical Sciences (LAPESF), Pharmacy Department (DepFarm), Rio de Janeiro State University (UERJ), Rio de Janeiro 23070-200, Brazil.ORCID 0000-0002-6322-7865 Paulo Cesar BastaProgram of Post-Graduation in Epidemiology in Public Health, National School of Public Health (ENSP), Oswald Cruz Foundation (Fiocruz), Rio de Janeiro 21040-900, Brazil.ORCID 0000-0003-0804-0413 Bruna Duarte PintoDepartment of Neurology, Hospital das Clínicas, Faculty of Medicine, University of São Paulo (USP), São Paulo 05403-000, Brazil.
Daniel Escorsim MachadoClinical Analysis Research Laboratory (LAPAC), Pharmacy Department (DepFarm), Rio de Janeiro State University (UERJ), Rio de Janeiro 23070-200, Brazil.ORCID 0000-0002-2640-8579 Felipe Oliveira Pessoa-SilvaResearch Laboratory of Pharmaceutical Sciences (LAPESF), Pharmacy Department (DepFarm), Rio de Janeiro State University (UERJ), Rio de Janeiro 23070-200, Brazil.ORCID 0009-0002-4502-8958 Rogério Adas Ayres de OliveiraFaculty of Medicine, University of São Paulo (USP), São Paulo 01246-903, Brazil.ORCID 0000-0002-0254-8497 Ana Claudia Santiago de VasconcellosLaboratory of Professional Education in Health Surveillance, Polytechnic School of Health Joaquim Venâcio (EPSJV), Oswald Cruz Foundation (Fiocruz), Rio de Janeiro 21040-900, Brazil.
Jamila Alessandra PeriniResearch Laboratory of Pharmaceutical Sciences (LAPESF), Pharmacy Department (DepFarm), Rio de Janeiro State University (UERJ), Rio de Janeiro 23070-200, Brazil.ORCID 0000-0002-7683-0698 Funding
Cnpq 301931/2025-9FAPERJ FAPERJ; E-26/200.437/2026; E-26/210.059/2023; E-26/210.014/2026; E-26/211.209/2021
6 · The paper itselfAbstract
Mercury (Hg) is a major neurotoxicant and public health concern and gold mining is a significant source of Hg contamination in the Amazon. There, Indigenous peoples are vulnerable to this exposure. Individual susceptibility influences both internal mercury levels and related clinical outcomes. In this context, the
Indexed as
Environmental PollutantsGlutathione S-Transferase piIndians, South AmericanMemoryMercuryAdultBrazilCross-Sectional StudiesFemaleGenotypeHairHumansMaleMiddle AgedPolymorphism, GeneticPolymorphism, Single NucleotideEnvironmental PollutantsGlutathione S-Transferase piGSTP1 protein, humanMercuryBrazilian AmazongeneticsGSTP1Indigenous peoplemercury exposuremethylmercuryneurotoxicity
Identifiers
PMID42354323
PMCPMC13299861
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390